- Report
- April 2025
- 276 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 205 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 246 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 64 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 376 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- January 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- May 2024
- 162 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 181 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 186 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2731EUR$3,000USD£2,319GBP

Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections.
The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings.
Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more